TEI9826

Known as: TEI-9826 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1998-2014
01219982014

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
The pseudoenantiomeric 4-O-Boc- and 4-OPMP-cyclopent-2-enones, readily available from hydroxymethylenefurane on multigram scale… (More)
Is this relevant?
2014
2014
We report Ir-catalyzed, enantioselective allylic substitution reactions of unstabilized silyl enolates derived from… (More)
Is this relevant?
2014
2014
Enantioselective conjugate addition of styrylboronic acid to dienones was effectively catalyzed by an O-monoacyltartaric acid to… (More)
  • table 1
  • table 2
Is this relevant?
2008
2008
A broadly applicable synthesis of chiral 2- or 2,4-substituted cyclopent-2-enones has been developed by combining asymmetric… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
Is this relevant?
2001
2001
13,14-Dihydro-15-deoxy-Delta7-prostaglandin A1 methyl ester (TEI-9826), an antitumor prostaglandin analog, is a candidate for… (More)
Is this relevant?
Review
2000
Review
2000
Antitumor prostaglandins(PGs) such as Delta12-PGJ2 and Delta7-PGA1 possess a cyclopentenone or cross-conjugated dienone… (More)
Is this relevant?
1999
1999
One of the delta7-prostaglandin A1 derivatives with unique antitumor activities, 13,14-dihydro-15-deoxy-delta7-prostaglandin-A1… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Review
1998
Review
1998
Antitumor Prostaglandins such as delta 12PGJ2 and delta 7PGA1 possess a cross-conjugated dienone unit and exhibit unique… (More)
Is this relevant?